$53.11 0.5%
VERX Stock Price vs. AI Score
Data gathered: January 2

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Vertex (VERX)

Analysis generated July 28, 2024. Powered by Chat GPT.

Vertex Pharmaceuticals Inc. is a global biotechnology company that engages primarily in the discovery, advancement, and commercialization of innovative therapies. The company focuses on serious diseases where there is a need for medical breakthroughs. Vertex is well-known for its work in cystic fibrosis and is exploring new areas such as pain, sickle cell disease, and beta-thalassemia. The company’s significant investment in R&D highlights its commitment to medical advancements and long-term growth potential.

Read full AI stock Analysis

Stock Alerts - Vertex (VERX)

company logo Vertex | December 19
Insider Alert: SCHWAB JOHN R is selling shares
company logo Vertex | December 17
Insider Alert: Westphal Jeffrey is selling shares
company logo Vertex | December 13
Insider Alert: DeStefano David is selling shares
company logo Vertex | December 12
Insider Alert: ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL u/a of JEFFREY R. WESTPHAL dated October 5, 2001 is selling shares

About Vertex

Vertex, Inc. provides tax technology solutions for retail, communication, leasing, retail trade, wholesale trade, technology, and manufacturing industries in the United States and internationally.


Vertex
Price $53.11
Target Price Sign up
Volume 116,150
Market Cap $8.32B
Year Range $29.13 - $56.92
Dividend Yield 0%
PE Ratio 280.79
Analyst Rating 56% buy
Industry Application Software

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24173M150M111M7.2M29M0.160
Q2 '24161M141M103M5.2M28M0.150
Q1 '24155M159M96M2.7M19M0.150
Q4 '23150M155M94M15M13M0.130
Q3 '23144M131M88M-3.4M16M0.100

Insider Transactions View All

SCHWAB JOHN R filed to sell 53,104 shares at $53.
December 18 '24
DeStefano David filed to sell 293,345 shares at $55.
December 12 '24
DeStefano David filed to sell 293,345 shares at $55.5.
December 12 '24
ITEM SECOND IRR. TRUST FBO KYLE R. WESTPHAL U/a Of JEFFREY R. WESTPHAL Dated October 5, 2001 filed to sell 1,283,100 shares at $55.
December 11 '24

What is the Market Cap of Vertex?

The Market Cap of Vertex is $8.32B.

What is Vertex's PE Ratio?

As of today, Vertex's PE (Price to Earnings) ratio is 280.79.

What is the current stock price of Vertex?

Currently, the price of one share of Vertex stock is $53.11.

How can I analyze the VERX stock price chart for investment decisions?

The VERX stock price chart above provides a comprehensive visual representation of Vertex's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Vertex shares. Our platform offers an up-to-date VERX stock price chart, along with technical data analysis and alternative data insights.

Does VERX offer dividends to its shareholders?

As of our latest update, Vertex (VERX) does not offer dividends to its shareholders. Investors interested in Vertex should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Vertex?

Some of the similar stocks of Vertex are Microsoft, Oracle, Adobe, Intuit, and Autodesk.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.